Trademark Overview
On Tuesday, January 21, 2025, a trademark application was filed for NEURALPLEXER with the United States Patent and Trademark Office. The USPTO has given the NEURALPLEXER trademark a serial number of 99014025. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, July 1, 2025. This trademark is owned by Iambic Therapeutics, Inc.. The NEURALPLEXER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Drug discovery services; platform as a service (PAAS) featuring a computer software platform for using artificial intelligence for collecting, analyzing, interpreting and reporting data and information in the field of drug design and development; platform as a service (PAAS) featuring a computer software platform for using artificial intelligence and machine learning for molecular docking; platform as a service (PAAS) featuring a computer software platform for using artificial intelligence for biomolecular structure prediction; platform as a service (PAAS) featuring a computer software platform for using artificial intelligence in the field of drug design and development; research and development of new therapeutic targets for others; scientific and medical research; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for collecting, analyzing, interpreting and reporting data and information in the field of drug design and develop...
